
Commentary|Slideshows|July 24, 2024
React to CVD Risk Factors: A Preventive Cardiology Guideline Topline
Author(s)Kenneth J. Bender, PharmD, MA
Based on guidance from the American Society of Preventive Cardiology, this topline summarizes risk factors and interventions to reduce the risk of major adverse CV events.
Advertisement
Part 1 of this Guideline Topline, "Elements of Preventive Cardiology," highlights the basics of primordial and primary cardiovascular disease prevention. This short part 2 slideshow summarizes the multiple risk factors for development of atherosclerotic CVD as well as evidence for pharmacotherapeutic intervention to reduce the risk of a major adverse CV event. Both Toplines are information condensed from "Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology."
Source: German CA, Baum SJ, Ferdinand KC, et al. Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology. Am J Prevent Cardiol. 2022;12;100432. doi:10.1016/j.ajpc.2022.100432
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
ACOG Releases New Guidance on HIV Screening and Prevention
2
2026 Dyslipidemia Guideline Expands Statin Eligibility to 21.5 Million More US Adults
3
From Amyloid Clearance to Daytime Function: Why Sleep Quality Matters for Brain Health
4
FDA Accepts Cefiderocol sNDA for Pediatric Gram-Negative Infections
5































































































































































